TransCode Therapeutics ( (RNAZ)) just unveiled an announcement. On December 19, 2025, TransCode Therapeutics appointed veteran life sciences executive Jack E. Stover to its board of directors, ...
BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...
BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company focused on immuno-oncology and RNA treatments for advanced cancer, announced Monday the appointment of Jack E. Stover to ...
The latest round of media company earnings reports confirmed once again that linear TV — cable in particular — is eroding quickly, with its decline in stark contrast with the growing streaming ...
WASHINGTON, Oct 24 (Reuters) - The U.S. will expand the use of facial recognition technology to track non-citizens entering and leaving the country in order to combat visa overstays and passport fraud ...
(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...
What happens when a trusted tech brand makes a decision that fundamentally alters how its products are used? For Synology, the answer is unfolding in real-time, as its recent move to eliminate ...
New integrations with Mimir, Iconik, Embrace, and Broadteam enhance interoperability and streamline workflows. Telestream to showcase these and more innovations at IBC2025. “Increasingly, our ...
National Grid Ventures (NGV) plans to install what it’s calling the world’s first commercially-deployed, 100% hydrogen-fueled linear generator in the world at its Northport Power Plant on Long Island ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback